Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22,471,910
-
Total 13F shares
-
3,569,988
-
Share change
-
+365,879
-
Total reported value
-
$2,955,323
-
Price per share
-
$0.83
-
Number of holders
-
32
-
Value change
-
+$299,071
-
Number of buys
-
13
-
Number of sells
-
9
Institutional Holders of iBio, Inc. - Common Stock (IBIO) as of Q3 2025
As of 30 Sep 2025,
iBio, Inc. - Common Stock (IBIO) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,569,988 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Ikarian Capital, LLC, AMERIPRISE FINANCIAL INC, Opaleye Management Inc., VANGUARD GROUP INC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.